Terug
Dagbereik
€ 1,56
€ 2,52
52-Weeksbereik
€ 0,56
€ 2,54
Volume
100
50D / 200D Gem.
€ 2,08
/
€ 2,00
Vorige Slotkoers
€ 1,56
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 469,2 | 0,3 |
| P/B | 10,5 | 2,9 |
| ROE % | 2,3 | 3,7 |
| Net Margin % | 7,3 | 3,8 |
| Rev Growth 5Y % | 28,2 | 10,0 |
| D/E | 0,5 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,00
€ 0,00 – € 0,00
|
200 M | 0 |
| FY2028 |
€ 0,00
€ 0,00 – € 0,00
|
190 M | 0 |
| FY2027 |
€ 0,07
€ 0,06 – € 0,08
|
210 M | 1 |
Belangrijkste Punten
Revenue grew 28,19% annually over 5 years — strong growth
Earnings declined -87,81% over the past year
ROE of 2,27% is below average
Debt/Equity of 0,49 — conservative balance sheet
Generating 30,44M in free cash flow
P/E of 469,21 — premium valuation
Groei
Revenue Growth (5Y)
28,19%
Revenue (1Y)-57,43%
Earnings (1Y)-87,81%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
2,27%
ROIC-0,88%
Net Margin7,29%
Op. Margin-5,73%
Veiligheid
Debt / Equity
0,49
Current Ratio2,82
Interest Coverage-0,62
Waardering
P/E Ratio
469,21
P/B Ratio10,47
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -57,43% | Revenue Growth (3Y) | -3,31% |
| Earnings Growth (1Y) | -87,81% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 28,19% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 38,10M | Net Income (TTM) | 2,78M |
| ROE | 2,27% | ROA | 1,29% |
| Gross Margin | 88,23% | Operating Margin | -5,73% |
| Net Margin | 7,29% | Free Cash Flow (TTM) | 30,44M |
| ROIC | -0,88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,49 | Current Ratio | 2,82 |
| Interest Coverage | -0,62 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 469,21 | P/B Ratio | 10,47 |
| P/S Ratio | 34,21 | PEG Ratio | -0,58 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,30B | Enterprise Value | 1,20B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 38,10M | 89,50M | 40,76M | 4,29M | 14,11M |
| Net Income | 2,78M | 22,80M | -137,55M | -137,32M | -296,48M |
| EPS (Diluted) | 0,00 | 0,03 | -0,19 | -0,19 | -0,39 |
| Gross Profit | 33,61M | 87,47M | 32,57M | -2,63M | 8,43M |
| Operating Income | -2,19M | 21,83M | -122,18M | -142,53M | -81,32M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 215,01M | 228,48M | 231,92M | 282,28M | 388,74M |
| Total Liabilities | 90,96M | 108,85M | 139,50M | 59,43M | 27,73M |
| Shareholders' Equity | 124,45M | 119,99M | 92,74M | 223,13M | 361,19M |
| Total Debt | 61,34M | 66,01M | 90,85M | 19,47M | 1,73M |
| Cash & Equivalents | 166,82M | 140,32M | 162,22M | 56,29M | 256,79M |
| Current Assets | 196,10M | 210,18M | 208,83M | 240,80M | 369,30M |
| Current Liabilities | 69,43M | 64,13M | 74,98M | 41,04M | 25,55M |